Seeking to shield its blockbuster eye drug against a second round of patent attacks, Allergan has transferred key Restasis intellectual property to the Saint Regis Mohawk Tribe. With the unusual move, the same company that touted pharma’s social contract with patients drew some quick and sharp responses, with some calling it innovative and others labeling it ‘sleazy.’
Read more here.
